An Intervention to Control Vasomotor Symptoms for Advanced PC Patients on Hormone Therapy

Abstract

During the past 12 months, we have received IRB approval from Mount Sinai School of Medicine, the James P. Peters VA Medical Center IRBs, and the Department of Defense. We have also held three focus groups with prostate cancer patients undergoing hormone therapy and multiple research team meetings were held to discuss focus group results, software development, and study protocol. We are currently integrating feedback from the final focus group into the vasomotor symptom intervention (VSI) and plan to run a final focus group to test the usability of the application. Our progress over the previous project period has led us to refine the methodology and software development, and this will allow us to begin the intervention phase during Y2 of the award.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Aug 01, 2012
Accession Number
ADA566715

Entities

People

  • Michael A. Diefenbach

Organizations

  • Icahn School of Medicine at Mount Sinai

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • African Americans
  • Beta Testing
  • Biological Sciences
  • Biomedical Research
  • Computing-Related Activities
  • Department Of Defense
  • Electronic Mail
  • Feedback
  • Information Security
  • Institutional Review Board
  • Intervention
  • Neoplasms
  • New York
  • Prostate
  • Prostate Cancer
  • Respiration
  • Software Development

Fields of Study

  • Medicine

Readers

  • Clinical Trial Research.
  • Psychological Intervention/Treatment for Stress, Anxiety, PTSD, and Related Emotional and Cognitive Health Symptoms.